We seem to be getting a cup and handle forming in LCI at the moment, a classic pattern favored by the O'Neil school of thought. In my book this is an excellent company going for a good price, and with current merger and acquisition activity in the sector I think it has a catalyst for investor interest. When a stock hits 50 on the Twiggs Momentum scale (50 day or...
Due to worse than expected ER, and lowered guidance, and top of all failed $AGN acquisition, it is very possible that $VRX is going to $90-$100 price level. Company is not profitable and even if their international profits rise (mostly Russia and Europe), there are problems in creating sustainable growth.
Boy, does VRX have shtty fundamental, but interesting technicals. I used to hate geometry when I was in high school, but it looks like it finally paid off. I used dotted line to visualize the way that VRX could've gone if the Allergan deal doesn't exist. VRX rallied 1000% in the last 4 years, the Allergan deal is like a life support machine for Valeant right...